Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Canakinumab for the treatment of adult-onset Still's disease.

Sfriso P, Bindoli S, Doria A, Feist E, Galozzi P.

Expert Rev Clin Immunol. 2020 Feb;16(2):129-138. doi: 10.1080/1744666X.2019.1707664. Epub 2020 Jan 18.

PMID:
31957508
2.

Correction to: Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Colafrancesco S, Manara M, Bortoluzzi A, Serban T, Bianchi G, Cantarini L, Ciccia F, Dagna L, Govoni M, Montecucco C, Priori R, Ravelli A, Sfriso P, Sinigaglia L; AOSD Consensus Group.

Arthritis Res Ther. 2020 Jan 9;22(1):6. doi: 10.1186/s13075-019-2094-5.

3.

Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.

Colafrancesco S, Manara M, Bortoluzzi A, Serban T, Bianchi G, Cantarini L, Ciccia F, Dagna L, Govoni M, Montecucco C, Priori R, Ravelli A, Sfriso P, Sinigaglia L; AOSD Consensus Group.

Arthritis Res Ther. 2019 Dec 11;21(1):275. doi: 10.1186/s13075-019-2021-9. Erratum in: Arthritis Res Ther. 2020 Jan 9;22(1):6.

4.

Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study.

Bindoli S, Franceschet G, Galozzi P, Zaninotto M, Camozzi V, Sfriso P.

Front Endocrinol (Lausanne). 2019 Sep 18;10:636. doi: 10.3389/fendo.2019.00636. eCollection 2019.

5.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

6.

Health-related quality of life, illness perception, coping strategies and the distribution of dependency in autoinflammatory diseases.

Cipolletta S, Giudici L, Punzi L, Galozzi P, Sfriso P.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):156-157. Epub 2019 Apr 26. No abstract available.

7.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

8.

Editorial: IL-1 Inhibition.

Oliviero F, Sfriso P, Punzi L, Dayer JM.

Front Pharmacol. 2019 Feb 12;10:87. doi: 10.3389/fphar.2019.00087. eCollection 2019. No abstract available.

9.

Role of blood inflammatory cells in chronic rhinosinusitis with nasal polyps.

Brescia G, Sfriso P, Marioni G.

Acta Otolaryngol. 2019 Jan;139(1):48-51. doi: 10.1080/00016489.2018.1538567. Epub 2019 Jan 28. Review.

PMID:
30686139
10.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

11.

Non-Eosinophilic Chronic Rhinosinusitis With Nasal Polyps: Eosinophil, Basophil, and Neutrophil Blood Counts Before and After Surgery.

Parrino D, Brescia G, Zanotti C, Tealdo G, Giacomelli L, Barion U, Sfriso P, Marioni G.

Ann Otol Rhinol Laryngol. 2018 Dec 17:3489418818578. doi: 10.1177/0003489418818578. [Epub ahead of print]

PMID:
30556407
12.

Development and Role in Therapy of Canakinumab in Adult-Onset Still's Disease.

Galozzi P, Baggio C, Bindoli S, Oliviero F, Sfriso P.

Front Pharmacol. 2018 Sep 21;9:1074. doi: 10.3389/fphar.2018.01074. eCollection 2018.

13.

Balneotherapy in chronic inflammatory rheumatic diseases-a narrative review.

Cozzi F, Ciprian L, Carrara M, Galozzi P, Zanatta E, Scanu A, Sfriso P, Punzi L.

Int J Biometeorol. 2018 Dec;62(12):2065-2071. doi: 10.1007/s00484-018-1618-z. Epub 2018 Oct 1. Review.

PMID:
30276474
14.

Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Sfriso P, Bindoli S, Galozzi P.

Drugs. 2018 Aug;78(12):1187-1195. doi: 10.1007/s40265-018-0956-9. Review.

PMID:
30069732
15.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
16.

Blood Eosinophil and Basophil Values Before and After Surgery for Eosinophilic-type Sinonasal Polyps.

Brescia G, Parrino D, Zanotti C, Tealdo G, Barion U, Sfriso P, Marioni G.

Am J Rhinol Allergy. 2018 May;32(3):194-201. doi: 10.1177/1945892418768590. Epub 2018 Apr 20.

PMID:
29676185
17.

Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.

Feist E, Quartier P, Fautrel B, Schneider R, Sfriso P, Efthimiou P, Cantarini L, Lheritier K, Leon K, Karyekar CS, Speziale A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):668-675. Epub 2018 Mar 2.

18.

Mechanism of Structural Tuning of the Hepatitis C Virus Human Cellular Receptor CD81 Large Extracellular Loop.

Cunha ES, Sfriso P, Rojas AL, Roversi P, Hospital A, Orozco M, Abrescia NGA.

Structure. 2018 Jan 2;26(1):181. doi: 10.1016/j.str.2017.11.015. No abstract available.

19.

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P.

Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. eCollection 2017.

20.

Clinical Overlapping in Autoinflammatory Diseases: The Role of Gene Duplication.

Galozzi P, Punzi L, Sfriso P.

Front Immunol. 2017 Apr 5;8:392. doi: 10.3389/fimmu.2017.00392. eCollection 2017. No abstract available.

21.

Mechanism of Structural Tuning of the Hepatitis C Virus Human Cellular Receptor CD81 Large Extracellular Loop.

Cunha ES, Sfriso P, Rojas AL, Roversi P, Hospital A, Orozco M, Abrescia NGA.

Structure. 2017 Jan 3;25(1):53-65. doi: 10.1016/j.str.2016.11.003. Epub 2016 Dec 1. Erratum in: Structure. 2018 Jan 2;26(1):181.

22.

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.

Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, Gentileschi S, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Rigante D, Cantarini L.

Front Pharmacol. 2016 Oct 24;7:380. eCollection 2016.

23.

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.

Sfriso P, Priori R, Valesini G, Rossi S, Montecucco CM, D'Ascanio A, Carli L, Bombardieri S, LaSelva G, Iannone F, Lapadula G, Alivernini S, Ferraccioli G, Colaci M, Ferri C, Iacono D, Valentini G, Costa L, Scarpa R, LoMonaco A, Bagnari V, Govoni M, Piazza I, Adami S, Ciccia F, Triolo G, Alessandri E, Cutolo M, Cantarini L, Galeazzi M, Ruscitti P, Giacomelli R, Caso F, Galozzi P, Punzi L.

Clin Rheumatol. 2016 Jul;35(7):1683-9. doi: 10.1007/s10067-016-3308-8. Epub 2016 May 20.

PMID:
27207567
24.

Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study.

Sfriso P, Caso F, Filardo GS, Botsios C, Costa L, Scarpa R, Todesco S, Spinella P, Oliviero F, Punzi L.

Clin Rheumatol. 2016 Jun;35(6):1615-8. doi: 10.1007/s10067-016-3244-7. Epub 2016 Apr 6.

PMID:
27048267
25.

Residues Coevolution Guides the Systematic Identification of Alternative Functional Conformations in Proteins.

Sfriso P, Duran-Frigola M, Mosca R, Emperador A, Aloy P, Orozco M.

Structure. 2016 Jan 5;24(1):116-126. doi: 10.1016/j.str.2015.10.025. Epub 2015 Dec 10.

26.

PACSAB: Coarse-Grained Force Field for the Study of Protein-Protein Interactions and Conformational Sampling in Multiprotein Systems.

Emperador A, Sfriso P, Villarreal MA, Gelpí JL, Orozco M.

J Chem Theory Comput. 2015 Dec 8;11(12):5929-38. doi: 10.1021/acs.jctc.5b00660. Epub 2015 Nov 20.

PMID:
26597989
27.

How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis.

Oliviero F, Spinella P, Fiocco U, Ramonda R, Sfriso P, Punzi L.

Swiss Med Wkly. 2015 Nov 2;145:w14190. doi: 10.4414/smw.2015.14190. eCollection 2015. Review.

28.

Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.

Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L.

RMD Open. 2015 Jul 20;1(1):e000097. doi: 10.1136/rmdopen-2015-000097. eCollection 2015. Review.

29.

The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.

Greco E, Aita A, Galozzi P, Gava A, Sfriso P, Negm OH, Tighe P, Caso F, Navaglia F, Dazzo E, De Bortoli M, Rampazzo A, Obici L, Donadei S, Merlini G, Plebani M, Todd I, Basso D, Punzi L.

Arthritis Res Ther. 2015 Apr 3;17:93. doi: 10.1186/s13075-015-0604-7.

30.

Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies.

Fredi M, Lazzaroni MG, Tani C, Ramoni V, Gerosa M, Inverardi F, Sfriso P, Caramaschi P, Andreoli L, Sinico RA, Motta M, Lojacono A, Trespidi L, Strigini F, Brucato A, Caporali R, Doria A, Guillevin L, Meroni PL, Montecucco C, Mosca M, Tincani A.

Autoimmun Rev. 2015 Aug;14(8):686-91. doi: 10.1016/j.autrev.2015.03.009. Epub 2015 Apr 7. Review.

PMID:
25858351
31.

Ex vivo and in vitro production of pro-inflammatory cytokines in Blau syndrome.

Galozzi P, Negm O, Greco E, Alkhattabi N, Gava A, Sfriso P, Fairclough L, Todd I, Tighe P, Punzi L.

Reumatismo. 2015 Mar 31;66(4):277-84. doi: 10.4081/reumatismo.2014.772.

32.

IL-1ß and IL-8 are scavenged by the hexadecylamide derivative of hyaluronic acid: a new mechanism.

Oliviero F, Scanu A, Ramonda R, Frallonardo P, Sfriso P, Dayer JM, Punzi L.

J Biomed Mater Res A. 2015 Sep;103(9):2823-9. doi: 10.1002/jbm.a.35422. Epub 2015 Feb 26.

PMID:
25689957
33.

Effects of half dose etanercept (25 mg once a week) on clinical remission and radiographic progression in patients with rheumatoid arthritis in clinical remission achieved with standard dose.

Raffeiner B, Botsios C, Ometto F, Bernardi L, Stramare R, Todesco S, Sfriso P, Punzi L.

Clin Exp Rheumatol. 2015 Jan-Feb;33(1):63-8. Epub 2014 Dec 22.

PMID:
25535985
34.

Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis.

Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM, Sfriso P, Verrecchia E, Tognon S, Bascherini V, Galeazzi M, Punzi L, Cantarini L.

Autoimmun Rev. 2014 Dec;13(12):1220-9. doi: 10.1016/j.autrev.2014.08.010. Epub 2014 Aug 23. Review.

PMID:
25182201
35.

Blau syndrome and latent tubercular infection: an unresolved partnership.

Caso F, Wouters CH, Rose CD, Costa L, Tognon S, Sfriso P, Cantarini L, Rigante D, Punzi L.

Int J Rheum Dis. 2014 Jun;17(5):586-7. doi: 10.1111/1756-185X.12330. Epub 2014 Mar 20. No abstract available.

PMID:
24646037
36.

The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.

Cantarini L, Rigante D, Merlini G, Vitale A, Caso F, Lucherini OM, Sfriso P, Frediani B, Punzi L, Galeazzi M, Cimaz R, Obici L.

Semin Arthritis Rheum. 2014 Jun;43(6):818-23. doi: 10.1016/j.semarthrit.2013.12.002. Epub 2013 Dec 12.

PMID:
24393624
37.

High-density lipoproteins inhibit urate crystal-induced inflammation in mice.

Scanu A, Luisetto R, Oliviero F, Gruaz L, Sfriso P, Burger D, Punzi L.

Ann Rheum Dis. 2015 Mar;74(3):587-94. doi: 10.1136/annrheumdis-2013-203803. Epub 2013 Dec 10.

PMID:
24326007
38.

Working the endless puzzle of hereditary autoinflammatory disorders.

Caso F, Cantarini L, Lucherini OM, Sfriso P, Fioretti M, Costa L, Vitale A, Atteno M, Galeazzi M, Muscari I, Magnotti F, Frediani B, Punzi L, Rigante D.

Mod Rheumatol. 2014 May;24(3):381-9. doi: 10.3109/14397595.2013.843755. Epub 2013 Oct 18. Review.

PMID:
24251993
39.

The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome.

Caso F, Costa L, Atteno M, Sfriso P, Cozzi F, Cantarini L, Scarpa R, Punzi L.

Int J Rheum Dis. 2013 Aug;16(4):495-6. doi: 10.1111/1756-185X.12138. Epub 2013 Jul 4. No abstract available.

PMID:
23992278
40.

Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database.

Scirè CA, Caporali R, Sarzi-Puttini P, Frediani B, Di Franco M, Tincani A, Sinigaglia L, Sfriso P, Tirri R, Bellis E, Delsante G, Porru G, Salaffi F, Giuggioli D, Rossini M, Todoerti M, Bazzichi L, Govoni M, Gerli R, Raschetti R, Minisola G, Montecucco C, Todesco S; Monitornet project.

Clin Exp Rheumatol. 2013 Nov-Dec;31(6):857-63. Epub 2013 Aug 26.

PMID:
23981363
41.

Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis.

Caso F, Fiocco U, Costa L, Sfriso P, Punzi L, Doria A.

Joint Bone Spine. 2014 Mar;81(2):190-2. doi: 10.1016/j.jbspin.2013.07.011. Epub 2013 Aug 9. No abstract available.

PMID:
23932926
42.

Exploration of conformational transition pathways from coarse-grained simulations.

Sfriso P, Hospital A, Emperador A, Orozco M.

Bioinformatics. 2013 Aug 15;29(16):1980-6. doi: 10.1093/bioinformatics/btt324. Epub 2013 Jun 5.

PMID:
23740746
43.

Epigallocatechin-3-gallate reduces inflammation induced by calcium pyrophosphate crystals in vitro.

Oliviero F, Sfriso P, Scanu A, Fiocco U, Spinella P, Punzi L.

Front Pharmacol. 2013 Apr 17;4:51. doi: 10.3389/fphar.2013.00051. eCollection 2013.

44.

Efficient Relaxation of Protein-Protein Interfaces by Discrete Molecular Dynamics Simulations.

Emperador A, Solernou A, Sfriso P, Pons C, Gelpi JL, Fernandez-Recio J, Orozco M.

J Chem Theory Comput. 2013 Feb 12;9(2):1222-9. doi: 10.1021/ct301039e. Epub 2012 Dec 28.

PMID:
26588765
45.

The occurrence of lower limb enthesopathy in coeliac disease patients without clinical signs of articular involvement.

Atteno M, Costa L, Tortora R, Cozzolino A, Del Puente A, Caso F, Sfriso P, Scarpa R, Ciacci C.

Rheumatology (Oxford). 2013 May;52(5):893-7. doi: 10.1093/rheumatology/kes380. Epub 2013 Jan 7.

PMID:
23300330
46.

Finding Conformational Transition Pathways from Discrete Molecular Dynamics Simulations.

Sfriso P, Emperador A, Orellana L, Hospital A, Gelpí JL, Orozco M.

J Chem Theory Comput. 2012 Nov 13;8(11):4707-18. doi: 10.1021/ct300494q. Epub 2012 Sep 6.

PMID:
26605625
47.

Response to 'Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4'.

Oliviero F, Scanu A, Dayer JM, Fiocco U, Sfriso P, Punzi L.

Arthritis Res Ther. 2012 Sep 12;14(5):405; author reply 406. doi: 10.1186/ar3863. No abstract available.

48.

Blau syndrome, clinical and genetic aspects.

Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L.

Autoimmun Rev. 2012 Nov;12(1):44-51. doi: 10.1016/j.autrev.2012.07.028. Epub 2012 Aug 2. Review.

PMID:
22884558
49.

Blockade of intra-articular TNF in peripheral spondyloarthritis: its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers.

Fiocco U, Sfriso P, Oliviero F, Lunardi F, Calabrese F, Scagliori E, Cozzi L, Di Maggio A, Nardacchione R, Molena B, Felicetti M, Gazzola K, Stramare R, Rubaltelli L, Accordi B, Costa L, Roux-Lombard P, Punzi L, Dayer JM.

Joint Bone Spine. 2013 Mar;80(2):165-70. doi: 10.1016/j.jbspin.2012.06.016. Epub 2012 Aug 3.

PMID:
22867975
50.

CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis.

Sfriso P, Cozzi F, Oliviero F, Caso F, Cardarelli S, Facco M, Fittà C, Del Rosso A, Matucci-Cerinic M, Punzi L, Agostini C.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S71-5. Epub 2012 May 29.

PMID:
22691213

Supplemental Content

Loading ...
Support Center